| Financial Year |
March 31 2023 |
| Monetary Funds |
1,157,920,222.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,226,610.22 |
| Accounts Receivable |
699,616,685.24 |
| Advances to Suppliers |
538,078,031.86 |
| Other Receivables |
181,743,972.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,341,996.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,550,141.74 |
| Total Current Assets |
2,651,218,362.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,193,830,340.30 |
| Investment Properties |
-- |
| Fixed Assetes |
8,427,290,576.69 |
| Under-construction Projects |
994,167,283.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
376,816,220.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,060,107.19 |
| Deferred Income Tax Assets |
55,575,387.72 |
| Other Non-Current Assets |
195,950,476.11 |
| Sub-Total of Non-Current Assets |
14,443,536,712.59 |
| Total Assets |
17,094,755,075.45 |
| Short-Term Loans |
1,801,082,188.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,334,730,000.00 |
| Accounts Payable |
626,212,787.23 |
| Accounts Received In Advance |
9,679,895.10 |
| Employee Compensation Payable |
29,119,475.91 |
| Taxes Payable |
5,537,977.16 |
| Interest Payable |
-- |
| Dividend Payable |
3,905,482.22 |
| Other payables |
102,245,608.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,651,092,753.62 |
| Other Current Liabilities |
796,593,692.87 |
| Sub-Total of Current Liabilities |
7,422,060,805.18 |
| Long-term Loans |
1,446,549,600.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
707,417,416.76 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,638,968.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,885,942,416.40 |
| Total Liabilities |
10,308,003,221.58 |
| Paid-In Capital(Or Share Stock) |
2,002,291,500.00 |
| Capital Surplus |
2,659,506,522.83 |
| Surplus Reserve |
556,493,380.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,453,707,846.63 |
| Minority Stockholder's Interest |
98,835,612.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,687,916,241.86 |
| Owner's Equity（Stockholder's Equity） |
6,786,751,853.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,094,755,075.45 |
